Literature DB >> 26236405

Some (dis)assembly required: partial unfolding in the Par-6 allosteric switch.

Dustin S Whitney1, Brian F Volkman1.   

Abstract

Allostery is commonly described as a functional connection between two distant sites in a protein, where a binding event at one site alters affinity at the other. Here we review the conformational dynamics that encode an allosteric switch in the PDZ domain of Par-6. Par-6 is a scaffold protein that organizes other proteins into a complex required to initiate and maintain cell polarity. NMR measurements revealed that the PDZ domain samples an evolutionarily conserved unfolding intermediate allowing rearrangement of two adjacent loop residues that control ligand binding affinity. Cdc42 binding to Par-6 creates a novel interface between the PDZ domain and the adjoining CRIB motif that stabilizes the high-affinity PDZ conformation. Thermodynamic and kinetic studies suggest that partial PDZ unfolding is an integral part of the Par-6 switching mechanism. The Par-6 CRIB-PDZ module illustrates two important structural aspects of protein evolution: the interface between adjacent domains in the same protein can give rise to allosteric regulation, and thermodynamic stability may be sacrificed to increase the sampling frequency of an unfolding intermediate required for conformational switching.

Entities:  

Year:  2015        PMID: 26236405      PMCID: PMC4519835          DOI: 10.1007/s12551-015-0164-8

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  44 in total

1.  Evolutionarily conserved pathways of energetic connectivity in protein families.

Authors:  S W Lockless; R Ranganathan
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

Review 2.  Nmr probes of molecular dynamics: overview and comparison with other techniques.

Authors:  A G Palmer
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001

3.  Structure of Cdc42 in a complex with the GTPase-binding domain of the cell polarity protein, Par6.

Authors:  Sarah M Garrard; Christopher T Capaldo; Lin Gao; Michael K Rosen; Ian G Macara; Diana R Tomchick
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

4.  Conversion of the enzyme guanylate kinase into a mitotic-spindle orienting protein by a single mutation that inhibits GMP-induced closing.

Authors:  Christopher A Johnston; Dustin S Whitney; Brian F Volkman; Chris Q Doe; Kenneth E Prehoda
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-11       Impact factor: 11.205

5.  Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain.

Authors:  H Tochio; Y K Mok; Q Zhang; H M Kan; D S Bredt; M Zhang
Journal:  J Mol Biol       Date:  2000-10-27       Impact factor: 5.469

6.  Binding to PKC-3, but not to PAR-3 or to a conventional PDZ domain ligand, is required for PAR-6 function in C. elegans.

Authors:  Jin Li; Heon Kim; Donato G Aceto; Jeffrey Hung; Shinya Aono; Kenneth J Kemphues
Journal:  Dev Biol       Date:  2010-02-01       Impact factor: 3.582

7.  Allosteric activation of the Par-6 PDZ via a partial unfolding transition.

Authors:  Dustin S Whitney; Francis C Peterson; Evgenii L Kovrigin; Brian F Volkman
Journal:  J Am Chem Soc       Date:  2013-06-12       Impact factor: 15.419

8.  Internal recognition through PDZ domain plasticity in the Par-6-Pals1 complex.

Authors:  Rhiannon R Penkert; Heather M DiVittorio; Kenneth E Prehoda
Journal:  Nat Struct Mol Biol       Date:  2004-10-10       Impact factor: 15.369

9.  Probing chemical shifts of invisible states of proteins with relaxation dispersion NMR spectroscopy: how well can we do?

Authors:  D Flemming Hansen; Pramodh Vallurupalli; Patrik Lundström; Philipp Neudecker; Lewis E Kay
Journal:  J Am Chem Soc       Date:  2008-02-01       Impact factor: 15.419

10.  par-6, a gene involved in the establishment of asymmetry in early C. elegans embryos, mediates the asymmetric localization of PAR-3.

Authors:  J L Watts; B Etemad-Moghadam; S Guo; L Boyd; B W Draper; C C Mello; J R Priess; K J Kemphues
Journal:  Development       Date:  1996-10       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.